Historical Intravenous Data Made CBD Bioavailability Estimates Approximate

The reported absolute bioavailability of a hemp cosmetic product was estimated using intravenous data from earlier research. It was not measured against an intravenous arm in the same participants.

The calculation crossed study boundaries

The paper reports estimated oral and topical CBD bioavailability of 10.18% and 0.69%. Its calculation combined route-specific exposure with previously published intravenous pharmacokinetic data. The current crossover compared oral and topical administration; it did not include an intravenous CBD treatment.

The reference data introduce uncertainty

Absolute bioavailability calculations depend on the reference exposure as well as the tested dose and route. The authors identify differences in populations, formulation, sampling duration and analytical methods as possible sources of variability when historical intravenous data are used. The numerical precision of the percentages does not remove those differences.

Observed exposure supports a narrower comparison

The trial’s measured concentration profiles supported greater systemic CBD exposure after oral administration than after application of this cosmetic oil. That within-study observation is different from establishing an exact fraction entering the circulation. The authors characterize the absolute estimates as approximate and hypothesis-generating. They should not be used as precise conversion factors between a person’s topical and oral doses, nor extended to other products without relevant data. Retaining the distinction between directly observed exposure and a historical-reference calculation makes the finding more useful rather than discarding it.

Related analysis: interpreting the study’s urine and plasma findings.

Research cited

Jain and colleagues. Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration. Pharmaceuticals (2026). DOI: 10.3390/ph19020231.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute Alpha-Pinene Tolerability Did Not Establish Long-Term Inhalation Safety

The alpha-pinene experiment supplied short-term human tolerability information under monitored conditions. It did not establish the safety of repeated inhalation over months or years. The experiment had a defined observation window Nineteen selected healthy adults completed the trial’s treatment conditions, with outcomes followed for six hours after exposure. Alpha-pinene alone…

Spread the love

Read Article: Acute Alpha-Pinene Tolerability Did Not Establish Long-Term Inhalation Safety

A Quiet Funnel Plot Could Not Rule Out Missing Cannabis Crash Studies

The older-driver review did not see obvious publication bias on funnel-plot inspection. With only a few studies per outcome, that observation could not establish that no relevant findings were missing. The two evidence pools were small The review included four collision-involvement studies and three culpability studies. Funnel plots were inspected…

Spread the love

Read Article: A Quiet Funnel Plot Could Not Rule Out Missing Cannabis Crash Studies

Removing One Study Reduced Cannabis Crash-Estimate Heterogeneity Without Producing Significance

A sensitivity analysis reduced inconsistency between the older-driver collision studies after one study was removed, but the pooled association remained nonsignificant. Greater consistency did not establish a precise or causal effect. The initial collision results varied substantially The review reported considerable heterogeneity among collision-involvement estimates. One included study showed a…

Spread the love

Read Article: Removing One Study Reduced Cannabis Crash-Estimate Heterogeneity Without Producing Significance

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us